Burlington, MA, United States of America

Aloysius O Anaebonam

This inventor holds 13 USPTO granted patents. Top assignees: Ascent Pharmaceuticals, Inc., Ascent Pediatrics, Inc., Fisons Ltd.. Active years: 1989-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aloysius O Anaebonam. Retrieved from https://idiyas.com/inventor/aloysius-o-anaebonam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 122(Granted Patents)


Location History:

  • Brookline, MA (US) (1989)
  • Burlington, MA (US) (1995 - 2001)

Company Filing History:


Years Active: 1989-2001

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Aloysius O Anaebonam: Innovations and Milestones in Extended Release Acetaminophen

Introduction:

Aloysius O Anaebonam, a visionary inventor based in Burlington, MA, has made significant contributions to the field of pharmaceuticals through his innovative mindset and technical expertise. With an impressive portfolio of 13 patents, Anaebonam's latest inventions revolve around extended release acetaminophen compositions. This article aims to explore his noteworthy achievements, career highlights, collaborations, and the impact of his inventions.

Latest Patents:

Anaebonam's patents focus on extended release acetaminophen compositions, targeting the controlled release of the active ingredient. The first patent pertains to an extended release acetaminophen composition comprising particles coated on sugar/starch seeds. This composition demonstrates controlled dissolution rates, with approximately 40% acetaminophen dissolution at thirty minutes and complete dissolution by six hours. The second patent relates to a plurality of discrete particles with acetaminophen, yielding controlled dissolution rates of 40% to 92%, exhibiting complete dissolution after six hours.

Career Highlights:

Throughout his career, Anaebonam has consistently pushed the boundaries of pharmaceutical innovation. His expertise in extended release formulations has enabled him to address critical challenges in drug delivery, enhancing patients' experiences and treatment outcomes. Anaebonam's contributions have significantly advanced the field of controlled drug release, demonstrating his determination to improve pharmaceutical solutions.

Collaborations:

Anaebonam's impressive career in the pharmaceutical industry includes collaborations with prominent companies such as Ascent Pharmaceuticals, Inc. and Ascent Pediatrics, Inc. These partnerships have facilitated the development and commercialization of his innovative extended release acetaminophen compositions. Additionally, Anaebonam has had the opportunity to collaborate with accomplished colleagues, including Emmett Clemente and Robert W Mendes, who have further amplified the impact of his inventions.

Conclusion:

Aloysius O Anaebonam has made significant strides in the field of extended release acetaminophen compositions, showcasing his innovative mindset and scientific expertise. His noteworthy patents have revolutionized drug delivery methods, allowing for controlled and effective release of acetaminophen in patients. Collaborations with established companies and renowned colleagues have further bolstered the impact of his inventions in the pharmaceutical industry. Anaebonam's contributions to medical science highlight the importance of ongoing advancements in drug delivery systems, ultimately enhancing patient well-being and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…